GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (XPAR:ERF) » Definitions » Days Sales Outstanding

Eurofins Scientific SE (XPAR:ERF) Days Sales Outstanding

: 58.03 (As of Dec. 2023)
View and export this data going back to 1997. Start your Free Trial

Eurofins Scientific SE's average Accounts Receivable for the six months ended in Dec. 2023 was €1,051 Mil. Eurofins Scientific SE's Revenue for the six months ended in Dec. 2023 was €3,305 Mil. Hence, Eurofins Scientific SE's Days Sales Outstanding for the six months ended in Dec. 2023 was 58.03.

The historical rank and industry rank for Eurofins Scientific SE's Days Sales Outstanding or its related term are showing as below:

XPAR:ERF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.34   Med: 63.39   Max: 73.1
Current: 58.93

During the past 13 years, Eurofins Scientific SE's highest Days Sales Outstanding was 73.10. The lowest was 54.34. And the median was 63.39.

XPAR:ERF's Days Sales Outstanding is ranked better than
66.22% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.24 vs XPAR:ERF: 58.93

Eurofins Scientific SE's Days Sales Outstanding declined from Dec. 2022 (59.09) to Dec. 2023 (58.03).


Eurofins Scientific SE Days Sales Outstanding Historical Data

The historical data trend for Eurofins Scientific SE's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.61 59.03 54.34 57.24 59.56

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.77 57.13 59.09 59.21 58.03

Competitive Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE Days Sales Outstanding Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Days Sales Outstanding falls into.



Eurofins Scientific SE Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Eurofins Scientific SE's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1053.3 + 1072.8) / 2 ) / 6514.6*365
=1063.05 / 6514.6*365
=59.56

Eurofins Scientific SE's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1029.2 + 1072.8) / 2 ) / 3305.1*365 / 2
=1051 / 3305.1*365 / 2
=58.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE  (XPAR:ERF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Eurofins Scientific SE Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (XPAR:ERF) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE (XPAR:ERF) Headlines

From GuruFocus

Enerplus: Investors Need to Consider This Stock for the Long Run

By Thriftyinvestments Thriftyinvestments 05-13-2015

ERF 8.2% Yield Put into Perspective

By Ilia Frankstein Ilia Frankstein 10-10-2011

ADVISORY RESEARCH INC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-17-2022

Enerplus Corporation Is a Stock to Stay Away From

By MacroConsultants MacroConsultants 04-27-2015